XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	18,010	18,130	19:15
	17,990	18,110	19:13

Realtime

Geld

Brief

Zeit

18,010

18,130

19:15

17,990

18,110

19:13

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.04.2024

Das Instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY wird ex Kapitalmassnahme gehandelt am 15.04.2024
The instrument L33 NO0012595950 DOLPHIN DRILL. A.S. NK 1 EQUITY is traded ex capital adjustment on 15.04.2024

Das Instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY wird cum Kapitalmassnahme gehandelt am 15.04.2024 und ex Kapitalmassnahme am 16.04.2024
The instrument TM9 NO0010360019 NORAM DRILLING CO. NK 2 EQUITY is traded cum capital adjustment on 15.04.2024 and ex capital adjustment on 16.04.2024

Das Instrument OND SE0009414576 ONCOPEPTIDES AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 15.04.2024 und ex Kapitalmassnahme am 16.04.2024
The instrument OND SE0009414576 ONCOPEPTIDES AB O.N. EQUITY is traded cum capital adjustment on 15.04.2024 and ex capital adjustment on 16.04.2024

Das Instrument IHCB NL0000360618 SBM OFFSHORE N.V. EO-,25 EQUITY wird cum Kapitalmassnahme gehandelt am 15.04.2024 und ex Kapitalmassnahme am 16.04.2024
The instrument IHCB NL0000360618 SBM OFFSHORE N.V. EO-,25 EQUITY is traded cum capital adjustment on 15.04.2024 and ex capital adjustment on 16.04.2024

Das Instrument N04A US67022C1062 NUCANA SP.ADR 1/ LS-,04 EQUITY wird cum Kapitalmassnahme gehandelt am 15.04.2024 und ex Kapitalmassnahme am 16.04.2024
The instrument N04A US67022C1062 NUCANA SP.ADR 1/ LS-,04 EQUITY is traded cum capital adjustment on 15.04.2024 and ex capital adjustment on 16.04.2024

Treibt Nvidias KI-Boom den Uranpreis?

In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.

Hier klicken

Zeit	Aktuelle Nachrichten
Mi	Dolphin Drilling getting over $20M for rig cancellation
Mi	EnQuest Cancels Dolphin Drilling's Rig Contract as Kraken Drilling Campaign Hits Hurdle
Mi	EnQuest Cancels Dolphin Drilling's Rig Contract as Kraken Drilling Program Hits Hurdle
Mi	Dolphin Drilling AS: Dolphin Drilling to receive payment of USD 20.75 million following Borgland Dolphin contract cancellation
11.11.	Dolphin Drilling's rig spins the drill bit in India as part of multi-well exploration ops

Zeit

Aktuelle Nachrichten

Dolphin Drilling getting over $20M for rig cancellation

EnQuest Cancels Dolphin Drilling's Rig Contract as Kraken Drilling Campaign Hits Hurdle

EnQuest Cancels Dolphin Drilling's Rig Contract as Kraken Drilling Program Hits Hurdle

Dolphin Drilling AS: Dolphin Drilling to receive payment of USD 20.75 million following Borgland Dolphin contract cancellation

11.11.

Dolphin Drilling's rig spins the drill bit in India as part of multi-well exploration ops

Zeit	Aktuelle Nachrichten
14.11.	NorAm Drilling AS - Third Quarter 2024 Results Presentation
14.11.	NorAm Drilling AS - Ex cash distribution USD 0.04 today
14.11.	XFRA CAPITAL ADJUSTMENT INFORMATION - 14.11.2024	Das Instrument 83W CA60007L1004 MILLBANK MINING CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 14.11.2024 und ex Kapitalmassnahme am 15.11.2024 The instrument 83W CA60007L1004 MILLBANK MINING CORP.... ► Artikel lesen
13.11.	NorAm Drilling AS - Third Quarter 2024 Results
07.11.	NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for November 2024

Zeit

Aktuelle Nachrichten

14.11.

NorAm Drilling AS - Third Quarter 2024 Results Presentation

14.11.

NorAm Drilling AS - Ex cash distribution USD 0.04 today

14.11.

XFRA CAPITAL ADJUSTMENT INFORMATION - 14.11.2024

Das Instrument 83W CA60007L1004 MILLBANK MINING CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 14.11.2024 und ex Kapitalmassnahme am 15.11.2024 The instrument 83W CA60007L1004 MILLBANK MINING CORP....
► Artikel lesen

13.11.

NorAm Drilling AS - Third Quarter 2024 Results

07.11.

NorAm Drilling AS - Monthly rig update and key information relating to the cash distribution for November 2024

Zeit	Aktuelle Nachrichten
11.11.	NuCana plc: NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel	Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-(L)1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival Following... ► Artikel lesen
26.09.	NuCana plc - 6-K, Report of foreign issuer
25.09.	NuCana secures new US patent for cancer treatment NUC-7738
25.09.	NuCana erhält neues US-Patent für Krebsbehandlung NUC-7738
25.09.	NuCana plc: NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States	EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738's... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11.11.

NuCana plc: NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-(L)1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival Following...
► Artikel lesen

26.09.

NuCana plc - 6-K, Report of foreign issuer

25.09.

NuCana secures new US patent for cancer treatment NUC-7738

25.09.

NuCana erhält neues US-Patent für Krebsbehandlung NUC-7738

25.09.

NuCana plc: NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738's...
► Artikel lesen

Zeit	Aktuelle Nachrichten
07.11.	Oncopeptides AB: Oncopeptides publishes Q3 report 2024	Stockholm - November 7, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the third quarter 2024. "In the... ► Artikel lesen
14.08.	Oncopeptides AB: Oncopeptides publishes Q2 report 2024	Stockholm - August 14, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the second quarter 2024. "During... ► Artikel lesen
30.05.	Oncopeptides AB: Oncopeptides publishes Q1 report 2024	Stockholm - May 30, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the first quarter 2024. "Seasonal... ► Artikel lesen

Zeit

Aktuelle Nachrichten

07.11.

Oncopeptides AB: Oncopeptides publishes Q3 report 2024

Stockholm - November 7, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the third quarter 2024. "In the...
► Artikel lesen

14.08.

Oncopeptides AB: Oncopeptides publishes Q2 report 2024

Stockholm - August 14, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the second quarter 2024. "During...
► Artikel lesen

30.05.

Oncopeptides AB: Oncopeptides publishes Q1 report 2024

Stockholm - May 30, 2024 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today publishes the report for the first quarter 2024. "Seasonal...
► Artikel lesen

Zeit	Aktuelle Nachrichten
18:23	SBM Offshore Completes $1.5 Bln Financing Of FPSO Jaguar
18:10	SBM Offshore N.V.: SBM Offshore completes US$1.5 billion financing of Jaguar	Amsterdam, November 21, 2024 SBM Offshore announces it has completed the project financing of FPSO Jaguar for a total of US$1.5 billion. The project financing was fully secured by a consortium... ► Artikel lesen
Mi	SBM Offshore N.V.: Weekly share repurchase program transaction details
Di	Exxon to Acquire 3 of 5 FPSOs It Has Leased from SBM Offshore by Yearend
14.11.	SBM Offshore's FPSO trio nearing finish line for first oil next year as ExxonMobil sets its cap on buying another Guyanese unit

Zeit

Aktuelle Nachrichten

18:23

SBM Offshore Completes $1.5 Bln Financing Of FPSO Jaguar

18:10

SBM Offshore N.V.: SBM Offshore completes US$1.5 billion financing of Jaguar

Amsterdam, November 21, 2024 SBM Offshore announces it has completed the project financing of FPSO Jaguar for a total of US$1.5 billion. The project financing was fully secured by a consortium...
► Artikel lesen

SBM Offshore N.V.: Weekly share repurchase program transaction details

Exxon to Acquire 3 of 5 FPSOs It Has Leased from SBM Offshore by Yearend

14.11.

SBM Offshore's FPSO trio nearing finish line for first oil next year as ExxonMobil sets its cap on buying another Guyanese unit